Intel stock spikes after report of possible US government stake
FREDERICK, Md. - TOMI Environmental Solutions, Inc. (NASDAQ:TOMZ), a $20.6 million market cap company showing strong revenue growth of 19% over the last twelve months, has received purchase orders from a global eye health company for its disinfection and decontamination products, according to a press release statement issued Tuesday.
The eye health company ordered multiple Surface Units and disinfection carts for its South Carolina facility earlier this year, followed by a second order for its Florida facility in the third quarter of 2025.
The South Carolina validation package was completed successfully, showing repeatable surface treatment results. TOMI’s SteraMist technology passed trials against Geobacillus stearothermophilus spores, which the company describes as a challenging industry benchmark for manual surface spraying.
The Florida facility is scheduled to undergo similar qualification testing in the near future.
TOMI expects the total purchases from this customer to reach approximately $385,000 in 2025, including equipment, solution, and support services. The company maintains a healthy gross profit margin of 46.8%, according to InvestingPro data, which also indicates the company has strong liquidity with current assets exceeding short-term obligations.
"We are incredibly proud to expand our partnership with this leader in global eye health," said Jim Reynolds, TOMI Manufacturing Sales Representative and President of ProEx Services.
TOMI Environmental Solutions specializes in disinfection and decontamination solutions through its Binary Ionization Technology platform, which uses ionized hydrogen peroxide technology. The company’s products are designed for various settings including hospitals, pharmaceutical facilities, and commercial buildings. With the stock showing a 40.5% return over the past year and trading near its Fair Value according to InvestingPro analysis, investors can access detailed insights and 7 additional ProTips about TOMZ’s financial health and growth prospects through the comprehensive Pro Research Report, available exclusively to subscribers.
In other recent news, TOMI Environmental Solutions reported a significant year-over-year increase in net revenue, reaching approximately $1.6 million for the first quarter of 2025, up from $1.1 million in the same quarter of the previous year. The company also reduced its total operating expenses to around $1.7 million in the first quarter of 2025, compared to $1.9 million in the first quarter of 2024. H.C. Wainwright analyst Amit Dayal maintained a Buy rating on TOMI Environmental Solutions, setting a price target of $3.50. Additionally, TOMI Environmental Solutions secured its fourth order for the SteraMist Integration System platform from ARES Distribution, intended for a biomedical research university in Florida, with delivery expected by late 2025. The company also completed the first installation of its SteraMist Integration System Standalone in the pharmaceutical isolator market. In a study published by the U.S. Department of Agriculture, TOMI’s disinfection technology showed promise in combating the Deformed Wing Virus, a threat to honeybee populations. Furthermore, TOMI Environmental Solutions appointed David Vanston as its new Chief Financial Officer, bringing over 25 years of financial leadership experience.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.